Michael Cloonan insider trades

Open-market stock purchases and sales by Michael Cloonan, President & CEO at Sionna Therapeutics, Inc, from SEC Form 4 filings since May 1, 2017.

Recent trades

DateStockTradeValue
Sep 17, 2026SION Sionna Therapeutics, IncBought (not open market)—
Sep 17, 2026SION Sionna Therapeutics, IncBought (not open market)—
Sep 17, 2026SION Sionna Therapeutics, IncSold (not open market)—
Jan 2, 2026SION Sionna Therapeutics, IncBought (not open market)—
Oct 21, 2025SION Sionna Therapeutics, IncSold$838K
Oct 21, 2025SION Sionna Therapeutics, IncSold$1.1M
Oct 21, 2025SION Sionna Therapeutics, IncSold$1.3M
Oct 21, 2025SION Sionna Therapeutics, IncBought (not open market)—
Oct 21, 2025SION Sionna Therapeutics, IncSold$459K
Oct 21, 2025SION Sionna Therapeutics, IncBought (not open market)—
Oct 21, 2025SION Sionna Therapeutics, IncBought (not open market)—
Oct 21, 2025SION Sionna Therapeutics, IncBought (not open market)—
Oct 16, 2025SION Sionna Therapeutics, IncSold$322K
Oct 16, 2025SION Sionna Therapeutics, IncSold$6.8K
Oct 16, 2025SION Sionna Therapeutics, IncBought (not open market)—
Oct 16, 2025SION Sionna Therapeutics, IncBought (not open market)—
Oct 15, 2025SION Sionna Therapeutics, IncSold$460K
Oct 15, 2025SION Sionna Therapeutics, IncBought (not open market)—

Companies traded

  • SION Sionna Therapeutics, Inc: 12 sales, last Sep 17, 2026
  • BLUE bluebird bio, Inc: other filings, last Jun 2, 2025
  • SAGE Sage Therapeutics, Inc: 1 sale, last Feb 10, 2021

Get free alerts when Michael Cloonan files a new trade →